Parataxis Korea파라택시스코리아
288330 · KOSDAQ · ₩288330 · 파라택시스코리아
- Market cap
- ₩44B
- Enterprise value
- ₩44B
- P/E
- —
- P/B
- 1.2×
- Dividend yield
- 0.0%
- ROE
- −91.2%
- Net margin
- −2,079.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−73.7% from the high
₩392Today: ₩416 – ₩416₩1,582
Returns
- 1W0.0%
- 1M0.0%
- 3M0.0%
- 6M0.0%
- YTD−53.6%
- 1Y−73.2%
- Volume today
- —
- Traded today
- —
- Listed shares
- 106,080,948
- EPS (12 months)
- −₩312
- Earnings yield −75.1%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumFlat0% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Parataxis Korea stock overview
Parataxis Korea (파라택시스코리아, KRX: 288330) is listed on KOSDAQ, in the Business services sector. The company operates two main businesses: a digital asset business that holds bitcoin as a strategic treasury asset and mines bitcoin using its own mining equipment, and a biotech business that researches and develops innovative drugs, mainly for idiopathic pulmonary fibrosis and cancer. Its shares closed at ₩416 on Oct 28, 2026, unchanged on the day, giving it a market value of ₩44B.
Key facts
- Market cap
- ₩44B
- Sector
- Business services
- Latest price change
- 0.00%
- As of
- Oct 28, 2026
- Main business
- The company operates two main businesses: a digital asset business that holds bitcoin as a strategic treasury asset and mines bitcoin using its own mining equipment, and a biotech business that researches and develops innovative drugs, mainly for idiopathic pulmonary fibrosis and cancer.
Quick answers about Parataxis Korea
- What does Parataxis Korea do?
- The company operates two main businesses: a digital asset business that holds bitcoin as a strategic treasury asset and mines bitcoin using its own mining equipment, and a biotech business that researches and develops innovative drugs, mainly for idiopathic pulmonary fibrosis and cancer. Its biotech model is to out-license clinical-stage drug candidates to pharmaceutical companies in Korea, Asia and global markets, with longer-term plans to commercialize its own drugs.
- What is the market cap of Parataxis Korea?
- The market capitalisation of Parataxis Korea was ₩44B at the close on Oct 28, 2026.
- Who are the largest shareholders of Parataxis Korea?
- According to the latest official filings, the largest reported holders are PARATAXISKOREAFUNDILLC (57.67%, as of Dec 29, 2025); PARATAXISHOLDINGSLLC (22.98%, as of Dec 29, 2025); SV Investment (4.15%, as of Mar 12, 2025).
- When is the next earnings report from Parataxis Korea?
- Korean companies rarely announce results dates in advance. Based on when Parataxis Korea filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
Company profile
The company operates two main businesses: a digital asset business that holds bitcoin as a strategic treasury asset and mines bitcoin using its own mining equipment, and a biotech business that researches and develops innovative drugs, mainly for idiopathic pulmonary fibrosis and cancer. Its biotech model is to out-license clinical-stage drug candidates to pharmaceutical companies in Korea, Asia and global markets, with longer-term plans to commercialize its own drugs.
Written by AI from the company's latest annual report.
- Korean name
- 파라택시스코리아
- Sector
- Business services
- Themes
- Crypto & digital assets
- CEO
- Andrew Kim
- Founded
- Sep 2015
- Listed
- Dec 2019
- Listed shares
- 106,080,948
- Fiscal year ends
- Month 12
- Website
- www.bridgebiorx.com
Similar companies
- S-1012750 · ₩3.6T₩95,100−0.21%
- Cheil Worldwide030000 · ₩2.1T₩18,510−2.63%
- Doosan Tesna131970 · ₩2T₩105,500+8.65%
- Lotte Tour Development032350 · ₩844B₩10,590+2.82%
- Soulbrain Holdings036830 · ₩791B₩38,600+2.52%
- Innocean Worldwide214320 · ₩702B₩17,560+1.15%
- Korea Ratings034950 · ₩456B₩100,500−0.30%
- Hanatour Service039130 · ₩436B₩28,150+3.87%
Recent filings
See all- [Amended] Suspension of Shareholder Register Closure or Record Date Setting (Extraordinary General Meeting – Withdrawn)Oct 6, 2026
- Amended: Shareholders' meeting calledOct 6, 2026
- Merger decisionOct 6, 2026
- Amended: Merger decisionOct 6, 2026
- Trading haltAug 20, 2026
Titles in Korean until English translations are added.
Also known as: Parataxis Korea / 파라택시스코리아 / 288330 / KRX:288330
Source: KRX statistical information